Exposure‐response Relationships of Etrolizumab in Patients with Moderately‐to‐severely Active Ulcerative Colitis
CPT Pharmacometrics & Systems Pharmacology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined